Open to all Yale affiliates, this program is designed to give an introduction to the field of biotechnology investment and acquire the knowledge of how to break into the industry.

Yale Biotech Club 2026 Bioinvestment & VC Series

Session goal: Examine exit pathways:  licensing deals, IPOs, and M&A and understand how exit strategies shape VC returns and company strategy.

Session 5: Strategic Growth & Exit Pathways       Featuring Ranjit Bindra, MD PhD; Professor at Yale, Serial Biotech Entrepreneur.

Arushi Dixit

Mirabel Solomon

Anne Sidamon-Eristoff

Stacy Li

Qiao Li

Ming Ma

Qianru Yang

Didier Rusangiza

Jessie Wang

Kevin Johnson

snpro

Ran Liu

Sara Ahmed

Standard